Investment Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,660
| Closed | -$254K | – | 258 |
|
|
2022
Q2 | $254K | Buy |
4,660
+17
| +0.4% | +$938 | 0.12% | 128 |
|
|
2022
Q1 | $253K | Sell |
4,643
-165
| -3% | -$8.96K | 0.11% | 142 |
|
|
2021
Q4 | $265K | Buy |
4,808
+18
| +0.4% | +$936 | 0.11% | 145 |
|
|
2021
Q3 | $229K | Buy |
4,790
+20
| +0.4% | +$1K | 0.1% | 150 |
|
|
2021
Q2 | $237K | Buy |
+4,770
| New | +$229K | 0.11% | 151 |
|
|
2020
Q3 | – | Sell |
-6,254
| Closed | -$319K | – | 136 |
|
|
2020
Q2 | $319K | Buy |
6,254
+1,065
| +21% | +$54.6K | 0.19% | 92 |
|
|
2020
Q1 | $246K | Sell |
5,189
-225
| -4% | -$12K | 0.18% | 100 |
|
|
2019
Q4 | $318K | Sell |
5,414
-131
| -2% | -$7.29K | 0.21% | 103 |
|
|
2019
Q3 | $296K | Buy |
5,545
+58
| +1% | +$2.98K | 0.22% | 99 |
|
|
2019
Q2 | $275K | Sell |
5,487
-374
| -6% | -$18.8K | 0.2% | 110 |
|
|
2019
Q1 | $306K | Buy |
5,861
+226
| +4% | +$11.3K | 0.22% | 97 |
|
|
2018
Q4 | $269K | Buy |
5,635
+25
| +0.4% | +$1.23K | 0.23% | 95 |
|
|
2018
Q3 | $231 | Sell |
5,610
-46
| -0.8% | -$2.34K | 0.13% | 105 |
|
|
2018
Q2 | $285K | Sell |
5,656
-1,891
| -25% | -$95.2K | 0.21% | 104 |
|
|
2018
Q1 | $369K | Buy |
7,547
+54
| +0.7% | +$2.52K | 0.27% | 80 |
|
|
2017
Q4 | $332K | Sell |
7,493
-5
| -0.1% | -$231 | 0.25% | 94 |
|
|
2017
Q3 | $381K | Sell |
7,498
-95
| -1% | -$4.82K | 0.33% | 75 |
|
|
2017
Q2 | $409K | Buy |
7,593
+61
| +0.8% | +$3.25K | 0.37% | 71 |
|
|
2017
Q1 | $397K | Buy |
7,532
+1,105
| +17% | +$56.1K | 0.38% | 71 |
|
|
2016
Q4 | $309K | Sell |
6,427
-3,506
| -35% | -$173K | 0.3% | 86 |
|
|
2016
Q3 | $535K | Buy |
9,933
+3,533
| +55% | +$194K | 0.3% | 89 |
|
|
2016
Q2 | $347K | Sell |
6,400
-3,386
| -35% | -$178K | 0.35% | 77 |
|
|
2016
Q1 | $494K | Buy |
9,786
+3,529
| +56% | +$176K | 0.32% | 85 |
|
|
2015
Q4 | $315K | Sell |
6,257
-31
| -0.5% | -$1.58K | 0.38% | 74 |
|
|
2015
Q3 | $303K | Sell |
6,288
-271
| -4% | -$14.1K | 0.4% | 71 |
|
|
2015
Q2 | $339K | Buy |
6,559
+11
| +0.2% | +$619 | 0.41% | 73 |
|
|
2015
Q1 | $378K | Sell |
6,548
-47
| -0.7% | -$2.69K | 0.42% | 73 |
|
|
2014
Q4 | $351K | Buy |
+6,595
| New | +$369K | 0.4% | 70 |
|
Other funds holding GSK
Investment Partners's GSK Position: Q3 2022 in Review
Investment Partners sold out of GSK (GSK) in Q3 2022, closing a stake of 4,660 shares — an estimated $254K sold.
Investment Partners first reported a position in GSK in Q4 2014 and held it in 28 quarters. The position peaked at $535K in Q3 2016. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.
- Investment Partners reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
- Investment Partners sold 4,660 GSK shares in Q3 2022, an estimated $254K.
- Investment Partners first reported a position in GSK in Q4 2014 and held it in 28 quarters.
- Investment Partners's GSK position peaked at $535K in Q3 2016.
- 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.
Based on Investment Partners's 13F filing for Q3 2022, filed 21 Oct 2022.